Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT05092373

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:28:38.447956+00:00

Published At

2026-01-14T00:00:00+00:00

Record Updated At

2026-01-14

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Advanced Breast Carcinoma", "Advanced Endometrial Carcinoma", "Advanced Fallopian Tube Carcinoma", "Advanced Hepatocellular Carcinoma", "Advanced Malignant Abdominal Neoplasm", "Advanced Malignant Female Reproductive System Neoplasm", "Advanced Malignant Thoracic Neoplasm", "Advanced Ovarian Carcinoma", "Advanced Primary Peritoneal Carcinoma", "Advanced Renal Cell Carcinoma", "Anatomic Stage III Breast Cancer AJCC v8", "Anatomic Stage IIIA Breast Cancer AJCC v8", "Anatomic Stage IIIB Breast Cancer AJCC v8", "Anatomic Stage IIIC Breast Cancer AJCC v8", "Anatomic Stage IV Breast Cancer AJCC v8", "Malignant Abdominal Neoplasm", "Malignant Solid Neoplasm", "Metastatic Breast Carcinoma", "Metastatic Endometrial Carcinoma", "Metastatic Fallopian Tube Carcinoma", "Metastatic Hepatocellular Carcinoma", "Metastatic Malignant Abdominal Neoplasm", "Metastatic Malignant Female Reproductive System Neoplasm", "Metastatic Malignant Thoracic Neoplasm", "Metastatic Ovarian Carcinoma", "Metastatic Primary Peritoneal Carcinoma", "Metastatic Renal Cell Carcinoma", "Prognostic Stage III Breast Cancer AJCC v8", "Prognostic Stage IIIA Breast Cancer AJCC v8", "Prognostic Stage IIIB Breast Cancer AJCC v8", "Prognostic Stage IIIC Breast Cancer AJCC v8", "Prognostic Stage IV Breast Cancer AJCC v8", "Stage III Fallopian Tube Cancer AJCC v8", "Stage III Hepatocellular Carcinoma AJCC v8", "Stage III Ovarian Cancer AJCC v8", "Stage III Primary Peritoneal Cancer AJCC v8", "Stage III Renal Cell Cancer AJCC v8", "Stage III Uterine Corpus Cancer AJCC v8", "Stage IIIA Fallopian Tube Cancer AJCC v8", "Stage IIIA Hepatocellular Carcinoma AJCC v8", "Stage IIIA Ovarian Cancer AJCC v8", "Stage IIIA Primary Peritoneal Cancer AJCC v8", "Stage IIIA Uterine Corpus Cancer AJCC v8", "Stage IIIA1 Fallopian Tube Cancer AJCC v8", "Stage IIIA1 Ovarian Cancer AJCC v8", "Stage IIIA2 Fallopian Tube Cancer AJCC v8", "Stage IIIA2 Ovarian Cancer AJCC v8", "Stage IIIB Fallopian Tube Cancer AJCC v8", "Stage IIIB Hepatocellular Carcinoma AJCC v8", "Stage IIIB Ovarian Cancer AJCC v8", "Stage IIIB Primary Peritoneal Cancer AJCC v8", "Stage IIIB Uterine Corpus Cancer AJCC v8", "Stage IIIC Fallopian Tube Cancer AJCC v8", "Stage IIIC Ovarian Cancer AJCC v8", "Stage IIIC Primary Peritoneal Cancer AJCC v8", "Stage IIIC Uterine Corpus Cancer AJCC v8", "Stage IIIC1 Uterine Corpus Cancer AJCC v8", "Stage IIIC2 Uterine Corpus Cancer AJCC v8", "Stage IV Fallopian Tube Cancer AJCC v8", "Stage IV Hepatocellular Carcinoma AJCC v8", "Stage IV Ovarian Cancer AJCC v8", "Stage IV Primary Peritoneal Cancer AJCC v8", "Stage IV Renal Cell Cancer AJCC v8", "Stage IV Uterine Corpus Cancer AJCC v8", "Stage IVA Fallopian Tube Cancer AJCC v8", "Stage IVA Hepatocellular Carcinoma AJCC v8", "Stage IVA Ovarian Cancer AJCC v8", "Stage IVA Primary Peritoneal Cancer AJCC v8", "Stage IVA Uterine Corpus Cancer AJCC v8", "Stage IVB Fallopian Tube Cancer AJCC v8", "Stage IVB Hepatocellular Carcinoma AJCC v8", "Stage IVB Ovarian Cancer AJCC v8", "Stage IVB Primary Peritoneal Cancer AJCC v8", "Stage IVB Uterine Corpus Cancer AJCC v8"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2026-01-14"

protocolSection.identificationModule.nctId

"NCT05092373"

protocolSection.identificationModule.officialTitle

"Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["PHASE1"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Advanced Breast Carcinoma (protocolSection.conditionsModule.conditions)
• Advanced Endometrial Carcinoma (protocolSection.conditionsModule.conditions)
• Advanced Fallopian Tube Carcinoma (protocolSection.conditionsModule.conditions)
• Advanced Hepatocellular Carcinoma (protocolSection.conditionsModule.conditions)
• Advanced Malignant Abdominal Neoplasm (protocolSection.conditionsModule.conditions)
• Advanced Malignant Female Reproductive System Neoplasm (protocolSection.conditionsModule.conditions)
• Advanced Malignant Thoracic Neoplasm (protocolSection.conditionsModule.conditions)
• Advanced Ovarian Carcinoma (protocolSection.conditionsModule.conditions)
• Advanced Primary Peritoneal Carcinoma (protocolSection.conditionsModule.conditions)
• Advanced Renal Cell Carcinoma (protocolSection.conditionsModule.conditions)
• Anatomic Stage III Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Anatomic Stage IIIA Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Anatomic Stage IIIB Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Anatomic Stage IIIC Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Anatomic Stage IV Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Malignant Abdominal Neoplasm (protocolSection.conditionsModule.conditions)
• Malignant Solid Neoplasm (protocolSection.conditionsModule.conditions)
• Metastatic Breast Carcinoma (protocolSection.conditionsModule.conditions)
• Metastatic Endometrial Carcinoma (protocolSection.conditionsModule.conditions)
• Metastatic Fallopian Tube Carcinoma (protocolSection.conditionsModule.conditions)
• Metastatic Hepatocellular Carcinoma (protocolSection.conditionsModule.conditions)
• Metastatic Malignant Abdominal Neoplasm (protocolSection.conditionsModule.conditions)
• Metastatic Malignant Female Reproductive System Neoplasm (protocolSection.conditionsModule.conditions)
• Metastatic Malignant Thoracic Neoplasm (protocolSection.conditionsModule.conditions)
• Metastatic Ovarian Carcinoma (protocolSection.conditionsModule.conditions)
• Metastatic Primary Peritoneal Carcinoma (protocolSection.conditionsModule.conditions)
• Metastatic Renal Cell Carcinoma (protocolSection.conditionsModule.conditions)
• Prognostic Stage III Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Prognostic Stage IIIA Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Prognostic Stage IIIB Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Prognostic Stage IIIC Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Prognostic Stage IV Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage III Fallopian Tube Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage III Hepatocellular Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage III Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage III Primary Peritoneal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage III Renal Cell Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage III Uterine Corpus Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIA Fallopian Tube Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIA Hepatocellular Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIA Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIA Primary Peritoneal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIA Uterine Corpus Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIA1 Fallopian Tube Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIA1 Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIA2 Fallopian Tube Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIA2 Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIB Fallopian Tube Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIB Hepatocellular Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIB Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIB Primary Peritoneal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIB Uterine Corpus Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIC Fallopian Tube Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIC Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIC Primary Peritoneal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIC Uterine Corpus Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIC1 Uterine Corpus Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIC2 Uterine Corpus Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IV Fallopian Tube Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IV Hepatocellular Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IV Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IV Primary Peritoneal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IV Renal Cell Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IV Uterine Corpus Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IVA Fallopian Tube Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IVA Hepatocellular Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IVA Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IVA Primary Peritoneal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IVA Uterine Corpus Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IVB Fallopian Tube Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IVB Hepatocellular Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IVB Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IVB Primary Peritoneal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IVB Uterine Corpus Cancer AJCC v8 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.